Not yet recruiting
Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT
NCT06075238
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China